Orthopedic Surgery: Complete Patient Guide to Procedures, Recovery, and Costs — Cost, Top Hospitals & Success Rates | MyMedicPlus

Orthopedic surgery (spelled orthopaedic surgery in British English) is the medical and surgical specialty concerned with the diagnosis, treatment, rehabilitation, and prevention of disorders affecting the musculoskeletal system — the bones, joints, cartilage, ligaments, tendons, muscles, and peripheral nerves that provide movement, support, and protection to the body.

The scope of modern orthopedic surgery is wide, encompassing both traumatic emergencies (open fractures, joint dislocations, traumatic tendon and ligament ruptures requiring urgent repair) and elective procedures planned after conservative management has been exhausted. Elective orthopedic surgery includes total knee and hip replacement for end-stage osteoarthritis, arthroscopic ligament reconstruction for sports injuries, spinal decompression and fusion for disc disease and instability, and deformity correction for congenital or post-traumatic skeletal malalignment.

Globally, orthopedic conditions account for a disproportionate share of the disability burden. The World Health Organization estimates that over 1.71 billion people live with musculoskeletal conditions, with osteoarthritis and low back pain consistently ranked among the leading causes of years lived with disability. Demand for joint replacement surgery is projected to grow by over 100% by 2040, driven by population ageing, rising obesity prevalence, and improving life expectancy.

Understanding what orthopedic surgery involves — when it is appropriate, which procedure is right, what to expect in terms of recovery, and how to evaluate costs and quality internationally — empowers patients to make informed, shared decisions with their surgical team. This guide provides a comprehensive overview for patients and their families considering orthopedic surgery anywhere in the world.

Total Knee Arthroplasty (TKA): Replacement of the entire knee joint surface — distal femur, proximal tibia, and patella — with metal components (femoral condyle and tibial tray, typically cobalt-chrome alloy) and an ultra-high molecular weight polyethylene (UHMWPE) insert. TKA is one of the most common elective surgical procedures globally, with over 1 million performed annually in the United States. Indications per NICE and AAHKS (American Association of Hip and Knee Surgeons) guidelines: severe knee pain and functional limitation due to osteoarthritis (most common), rheumatoid arthritis, or post-traumatic arthritis, failing to respond to at least 3 months of conservative management. 15-year implant survival exceeds 95% at high-volume centres.

Total Hip Arthroplasty (THA): Replacement of the femoral head (with a metal or ceramic ball on a titanium stem) and the acetabulum (with a metal shell and UHMWPE or ceramic liner). The bearing couple — the articulating surface between head and liner — is the primary determinant of long-term wear: ceramic-on-ceramic has lowest wear rates but higher fracture risk; highly crosslinked polyethylene (XLPE) paired with ceramic or cobalt-chrome heads is now the most widely used combination with excellent longevity.

Arthroscopy: Minimally invasive keyhole joint surgery using a small camera (arthroscope) and working instruments through 2–3 small portals. Performed as day surgery. Applications include: knee — ACL reconstruction, meniscal repair/partial meniscectomy, cartilage restoration; shoulder — rotator cuff repair, Bankart labral repair, subacromial decompression; hip — labral repair, cam/pincer FAI correction; ankle — osteochondral defect treatment, ligament repair.

Open Reduction and Internal Fixation (ORIF): Surgical restoration of anatomic alignment of fractures followed by internal fixation with metal hardware (plates, screws, intramedullary nails, wires). Indications include displaced intra-articular fractures (tibial plateau, distal radius, ankle), unstable diaphyseal fractures, periarticular fractures around prosthetic implants, and fractures that are not reducible by closed manipulation.

Spinal Fusion: Surgical joining of two or more vertebral levels using bone graft and instrumentation (pedicle screws, rods, cages), eliminating motion at the fused segment. Indications include spondylolisthesis (vertebral slippage), spinal instability, degenerative disc disease with refractory pain, deformity (scoliosis, kyphosis), and failed previous disc surgery. Approaches include posterior lumbar interbody fusion (PLIF), transforaminal lumbar interbody fusion (TLIF), and lateral lumbar interbody fusion (LLIF).

Ligament Reconstruction: ACL (anterior cruciate ligament) reconstruction using autograft (patellar tendon bone-patellar tendon-bone, hamstring tendon) or allograft tissue, restoring knee stability after rupture. Success rates for return to sport exceed 85% with structured rehabilitation. PCL, MCL, posterolateral corner, and multiligament knee reconstructions address complex instability patterns.

Tendon Repair: Surgical repair of complete tendon ruptures — Achilles tendon (acute end-to-end repair or reconstructive procedures for chronic ruptures); rotator cuff (arthroscopic anchor-based repair); biceps tendon (distal and proximal repair); extensor mechanism (quadriceps or patellar tendon).

The decision to proceed with orthopedic surgery requires careful integration of clinical symptoms, functional limitation, imaging findings, and patient goals. A guiding principle common to all elective orthopedic surgery is imaging-symptom correlation — radiographic or MRI findings must correspond to the patient's clinical presentation. Incidental degenerative changes on imaging in asymptomatic individuals are not indications for surgery.

When is surgery appropriate? Surgery is generally indicated when: (1) conservative management — physiotherapy, analgesia, activity modification, and appropriate injections — has been undertaken for a minimum of 3–6 months without adequate relief; (2) symptoms significantly limit function affecting activities of daily living, work, or quality of life; (3) imaging demonstrates pathology concordant with clinical symptoms; and (4) the patient is medically fit and psychologically ready for surgery and its rehabilitation demands.

Pre-operative medical assessment: All patients undergoing elective orthopedic surgery require systematic pre-operative evaluation. The Revised Cardiac Risk Index (RCRI) — a validated six-factor score — stratifies cardiac complication risk for non-cardiac surgery and guides the need for cardiology referral and investigation. Patients with significant cardiac, respiratory, or renal comorbidity may require anaesthesia-led pre-operative optimisation. Uncontrolled diabetes (HbA1c >69 mmol/mol / >8.5%) significantly increases infection and wound healing complication risk and should be optimised before elective surgery. Obesity (BMI >40) carries increased VTE, infection, and anaesthetic risk — many high-volume centres recommend weight reduction to BMI below 35–40 before elective TKA/THA.

Functional status assessment: Pre-operative PROM completion (Oxford Knee/Hip Score, KOOS/HOOS, EQ-5D) establishes a baseline against which post-operative improvement is measured. Frailty screening (Clinical Frailty Scale, FRAIL scale) in elderly patients identifies high-risk individuals who may benefit from pre-operative prehabilitation — structured exercise, nutritional optimisation, and anaemia treatment — to reduce complication rates and improve recovery.

VTE risk assessment: Caprini or RCOG/NICE risk stratification guides the intensity and duration of thromboprophylaxis. Anticoagulant management in patients already on warfarin or DOACs for AF or previous VTE requires liaison between the surgical and anticoagulation teams for safe bridging protocols.

Pre-operative coagulopathy reversal: Patients on warfarin require reversal to INR below 1.5 before elective surgery, achieved with vitamin K or 4-factor prothrombin complex concentrate (4F-PCC) if urgent. DOAC management involves timed omission based on renal function and drug half-life; reversal agents (andexanet alfa for factor Xa inhibitors; idarucizumab for dabigatran) are available for emergencies.

Minimally invasive surgery (MIS) vs open approaches: Minimally invasive techniques use shorter incisions with muscle-sparing dissection, reducing blood loss, post-operative pain, and recovery time. MIS TKA and THA use specialised instrumentation to implant standard components through reduced-length incisions (8–10 cm for MIS THA vs 20–25 cm traditional). The direct anterior approach for THA is fully intermuscular (no muscle detachment), enabling faster early recovery and a lower dislocation rate. However, MIS approaches have a steeper learning curve and do not demonstrate superior long-term outcomes compared to expertly performed conventional approaches — surgeon familiarity and volume are more important determinants of outcome than incision length.

Robotic-assisted orthopedic surgery: The MAKO system (DePuy Synthes / Johnson & Johnson) uses pre-operative CT-based 3D planning and intra-operative haptic feedback to guide bone resection within planned boundaries during TKA, THA, and unicompartmental knee replacement. The ROSA system (Zimmer Biomet) uses image-based or imageless workflows for TKA. Multiple randomised controlled trials and registry studies demonstrate that robotic assistance significantly reduces implant positioning outliers and improves mechanical axis restoration compared to conventional instrumentation. Long-term implant survival superiority is plausible but not yet proven in 15+ year follow-up data. Robotic surgery adds approximately USD 2,000–5,000 per case; many high-volume centres absorb this in total case costs.

Blood conservation — tranexamic acid (TXA): TXA is an antifibrinolytic agent that inhibits plasminogen activation, reducing surgical bleeding by 30–50% in joint replacement. The OPTIMAL trial (2022, NEJM Evidence) demonstrated equivalent blood conservation efficacy among intravenous (IV), oral, and intra-articular (IA) administration routes of TXA in primary TKA — with no statistically significant difference in transfusion rates, haemoglobin drop, or thromboembolic events between routes. This allows centres to choose the most operationally convenient administration method without sacrificing efficacy. TXA reduces allogenic blood transfusion requirement from approximately 15–20% (pre-TXA era) to below 2% in primary joint replacement.

Regional anaesthesia — peripheral nerve blocks (PNB): Spinal anaesthesia (intrathecal bupivacaine) combined with peripheral nerve block has largely replaced general anaesthesia for lower-limb orthopedic surgery at ERAS-compliant centres. For TKA, adductor canal block (ACB) provides effective quadriceps-sparing analgesia (motor-preserving, allowing immediate mobilisation) superior to femoral nerve block for early rehabilitation. For THA, pericapsular nerve group block (PENG) or fascia iliaca block provides post-operative analgesia. Peripheral nerve blocks reduce opioid consumption by 30–50%, accelerate mobilisation, and reduce post-operative nausea and vomiting — a key ERAS benefit.

Implant materials:

• Titanium alloy (Ti-6Al-4V): Used for femoral stems (THA), tibial trays (TKA), and acetabular shells — excellent osseointegration for cementless fixation, high fatigue strength, MRI-compatible with reduced artefact vs cobalt-chrome
• Cobalt-chromium alloy (CoCr): Used for femoral heads, femoral condyle components, and modular taper junctions — higher hardness and scratch resistance than titanium; corrosion at taper junctions (trunnionosis) can release metal ions in susceptible implant designs
• Ultra-high molecular weight polyethylene (UHMWPE): Used for acetabular and tibial insert liners — bears the articulating load. Highly crosslinked UHMWPE (XLPE) has wear rates 90%+ lower than conventional polyethylene, dramatically reducing osteolysis and revision rates at 15+ years
• Ceramic (alumina/zirconia-toughened alumina — ZTA): Used for femoral heads and acetabular liners in ceramic-on-ceramic (CoC) bearings — lowest wear rates of all bearing couples; risk of squeaking (0.5–2%) and catastrophic fracture (0.001–0.01%); not suitable for revision due to third-body wear risk

Orthopedic surgery, when appropriately indicated, delivers some of the most durable and measurable functional improvements in all of medicine. National registry data and clinical trial evidence document consistent, large-magnitude gains across procedures.

Joint replacement (TKA/THA): The most consistently successful elective surgical procedures in terms of patient satisfaction. Oxford Knee and Hip Scores improve by an average of 20–25 points (on a 0–48 scale) following successful primary arthroplasty. Approximately 85–90% of patients report being satisfied or very satisfied at 1-year follow-up. Pain relief is typically rapid and dramatic — most patients report the best sleep in years within weeks of surgery, liberated from the constant aching of end-stage arthritis. Functional capacity — walking distance, stair climbing, returning to recreational activities — improves markedly in the majority.

15-year implant survival: For primary TKA and THA using contemporary implant systems with highly crosslinked polyethylene, 15-year implant survival rates exceed 95% at high-volume registry centres (AOANJRR, NJR data). This means the large majority of patients who undergo primary joint replacement in their 60s and 70s will not need revision surgery in their lifetime.

ACL reconstruction: Returns 80–85% of athletes to their pre-injury sport level by 9–12 months with protocol-adherent rehabilitation. Prevents secondary meniscal damage and articular cartilage loss from recurrent instability — a major long-term benefit given the 10-fold increase in early-onset knee OA associated with untreated ACL deficiency with meniscal involvement.

Spinal surgery benefits: Microdiscectomy provides faster, more complete relief of leg pain (sciatica) than extended conservative management (SPORT trial). Lumbar decompression for spinal stenosis significantly improves walking distance and neurogenic claudication symptoms. ACDF reliably eliminates cervical radiculopathy and, in myelopathic patients, halts neurological deterioration and often achieves partial recovery.

Economic benefits: Successful orthopedic surgery reduces long-term analgesic and healthcare utilisation, returns patients to work and productive activity, and prevents the downstream health consequences of prolonged disability and immobility. Cost-effectiveness analyses consistently demonstrate that primary TJR falls well below accepted willingness-to-pay thresholds per QALY gained.

All orthopedic surgical procedures carry inherent risks. Understanding these risks — and their likelihood in the context of the specific procedure, hospital volume, and individual patient factors — is essential to informed consent and realistic expectation-setting.

Venous thromboembolism (VTE): Deep vein thrombosis (DVT) and pulmonary embolism (PE) are the most common serious preventable complications of lower-limb orthopedic surgery. Without prophylaxis, DVT occurs in up to 60% of unprotected TKA patients (most asymptomatic). Current standard of care — pharmacological prophylaxis with LMWH or a DOAC (rivaroxaban/apixaban), early mobilisation, and pneumatic compression — reduces symptomatic VTE to below 1%. Prophylaxis is continued for 14 days post-TKA and 35 days post-THA per NICE NG89.

Infection: Superficial wound infection (cellulitis, seroma) occurs in 1–3% and usually responds to antibiotics and wound care. Periprosthetic joint infection (PJI) — deep infection involving the implant — occurs in 1–2% of primary arthroplasties and is the most devastating complication. It typically requires prolonged antibiotic therapy and often two-stage revision surgery (spacer placement, 6–12 weeks of IV antibiotics, reimplantation). Prevention: peri-operative antibiotics (cefazolin IV within 60 minutes of incision), skin antisepsis (chlorhexidine), laminar flow theatres, and meticulous surgical technique.

Implant-related failure: Aseptic loosening (implant losing fixation to bone due to wear debris-induced osteolysis) was historically the leading long-term cause of revision; modern XLPE has substantially reduced this. Instability and dislocation (hip arthroplasty — 2–4% posterior approach); patellar complications (TKA — anterior knee pain, patellar fracture, patellar clunk syndrome); periprosthetic fracture (1–3% at 10 years); and stiffness requiring manipulation under anaesthesia (TKA — 1–3%).

Nerve and vascular injury: Peroneal nerve palsy following TKA (1–2%) or tibial osteotomy. Sciatic nerve palsy following THA (0.3–0.7%), more common with leg lengthening. Vascular injury to popliteal vessels is rare but catastrophic — requires immediate vascular surgery consultation. Radial nerve injury after humeral shaft fixation (posterior approach). Most nerve injuries are neuropraxias that recover within weeks to months; complete transection is rare.

Metal-on-metal (MoM) implant concerns: Certain MoM hip implants (DePuy ASR, Zimmer Durom, Biomet M2A) cause adverse local tissue reactions (ALTR) from cobalt-chromium wear debris, leading to metallosis, pseudotumours, bone destruction, and systemic cobalt/chromium toxicity. MHRA Medical Device Alert (2012) mandates annual surveillance (serum ion levels, MARS MRI) for all patients with large-head MoM hip implants. New MoM hip implants are no longer implanted in the UK.

Surgical approach-specific risks: Intraoperative fracture (calcar crack with cementless stems — 1–3%); excessive leg length change post-THA (usually within 1–2 cm, rarely symptomatic); heterotopic ossification (1–5% after THA — higher risk with traumatic approach or previous HO); cement embolism syndrome (BCIS) with cemented fixation.

Rehabilitation after orthopedic surgery is as important as the surgery itself — the quality and consistency of post-operative physiotherapy directly determines the final functional outcome, particularly for joint replacement and ligament reconstruction.

Joint replacement rehabilitation (ERAS pathway): Under modern ERAS protocols, physiotherapy begins on the day of surgery — patients stand and take first steps within hours of TKA or THA, while the spinal block is still partially present and post-operative analgesia is at peak effectiveness. Inpatient physiotherapy focuses on safe transfers, initial gait training with a walking aid, basic exercises (ankle pumps, quad sets, heel slides), and stair negotiation. Most ERAS patients are discharged home on day 0 or 1.

Outpatient physiotherapy continues for 6–12 weeks: early goals include achieving full knee extension (TKA), 90° flexion at 6 weeks, and full weight-bearing gait; later goals include progressive strengthening, balance training, and return to recreational activities at 3–6 months. Maximum functional improvement may continue for 12–24 months post-arthroplasty.

ACL reconstruction rehabilitation: Return to sport protocol spans approximately 9–12 months for competitive athletes — this timeframe reflects the biological maturation of the graft (ligamentisation) rather than just the clinical recovery. Milestones include: 0–2 weeks (swelling and pain management, range of motion restoration); 2–6 weeks (progressive weight-bearing, quadriceps activation); 6–12 weeks (strength training, proprioception); 3–6 months (functional training, agility); 6–9 months (sport-specific drills); 9–12 months (return to full competition if criteria met). Criteria-based return to sport — quadriceps symmetry index >90%, hop test symmetry, psychological readiness — is preferred over time-based return to reduce re-rupture rates.

Spinal surgery recovery: After lumbar microdiscectomy, most patients are mobilised on day 1 and discharged within 1–2 days. Return to sedentary work at 2–4 weeks; manual work at 6–12 weeks. After spinal fusion, return to work is at 6–12 weeks for office work; 3–6 months for heavy manual labour. Physiotherapy commences at 6 weeks post-fusion, focusing on core stabilisation and spinal mobility.

Long-term follow-up: Annual radiographic and clinical review for arthroplasty patients — particularly important for detecting early osteolysis, component migration, or developing instability before catastrophic failure. PROM collection at 6 months and 5 years tracks outcomes against national benchmarks. Patients should report new-onset pain, swelling, or functional deterioration to their orthopedic team promptly rather than waiting for scheduled reviews.

Orthopedic surgery is the most common area for medical tourism globally. The combination of long waiting times in public healthcare systems, high private costs in Western countries, and the high-quality, affordable care available internationally drives millions of patients to seek elective orthopedic surgery abroad each year.

What drives orthopedic surgery costs?

• Procedure complexity: Primary procedures are substantially cheaper than revisions; bilateral simultaneous surgery costs less per side than staged bilateral
• Implant selection: Premium implants (oxidised zirconium femoral heads, ceramic CoC bearings, patient-specific instrumentation, robotic systems) add implant and equipment costs of USD 1,500–8,000 per case
• Fixation method: Uncemented fixation uses pricier titanium porous-coated implants; cemented fixation adds cement cost but uses lower-cost basic implant designs
• Hospital infrastructure: Laminar flow theatres, robotic systems, high-dependency units, and specialist nursing add to total hospital costs
• Surgeon subspecialty and volume: High-volume fellowship-trained arthroplasty or spine surgeons typically have lower complication rates but may charge higher fees
• Rehabilitation: Inpatient vs outpatient physiotherapy; duration of home physiotherapy programme

Country cost comparison (USD, 2026 estimates — all-inclusive):

• Total Knee Arthroplasty (TKA): USA USD 30,000–60,000 | UK (private) GBP 12,000–22,000 | India USD 5,000–10,000 | Thailand USD 12,000–18,000 | Turkey USD 8,000–14,000 | Hungary/Poland USD 8,000–13,000
• Total Hip Arthroplasty (THA): USA USD 32,000–65,000 | UK (private) GBP 13,000–24,000 | India USD 5,500–11,000 | Thailand USD 13,000–20,000 | Turkey USD 9,000–15,000
• ACL Reconstruction: USA USD 15,000–30,000 | India USD 2,500–5,000 | Thailand USD 7,000–12,000
• Lumbar Spinal Fusion (1-level TLIF): USA USD 50,000–100,000 | India USD 6,000–12,000 | Thailand USD 15,000–25,000

Quality assurance when seeking care abroad: Verify JCI or NABH hospital accreditation; confirm the surgeon holds FRCS(Orth), ABOS, or MCh Ortho or equivalent international fellowship; review the implant brand and model proposed (cross-reference against national registry revision rates); ensure a clear care transfer plan exists with your home orthopedic team; and purchase comprehensive travel health insurance including medical repatriation coverage before departure.

Surgery should rarely be the first resort for orthopedic conditions. A comprehensive, supervised trial of conservative management is appropriate before most elective procedures, and some conditions are effectively managed non-operatively long-term.

Physiotherapy and structured exercise: The highest evidence-level non-surgical intervention for most musculoskeletal conditions. The NICE guideline for knee osteoarthritis recommends a minimum 12-week supervised exercise programme before arthroplasty consideration. Exercise improves pain, function, and muscle strength; reduces perioperative risk if surgery becomes necessary; and for a proportion of patients with knee OA provides sufficient relief to defer or avoid surgery indefinitely. Specific exercise prescriptions include: quadriceps strengthening, cycling, and hydrotherapy for knee OA; hip abductor strengthening for hip OA; McKenzie exercises and neural mobilisation for lumbar disc herniation; rotator cuff strengthening for shoulder impingement.

Weight management: Every 1 kg reduction in body weight reduces knee joint loading by approximately 4 kg with each step. Weight loss combined with exercise therapy is more effective than either alone for knee OA. Achieving BMI below 35 before arthroplasty substantially reduces infection, wound, and anaesthetic complication rates.

Pharmacological management: NSAIDs (oral naproxen, topical diclofenac) provide the most evidence-based pharmacological relief for OA. Duloxetine (a serotonin-noradrenaline reuptake inhibitor) is approved for chronic pain and OA. Opioids should be avoided or strictly limited for chronic musculoskeletal pain given dependency risk and lack of long-term efficacy. Bone-modifying agents (alendronate, zoledronic acid, denosumab) for osteoporosis reduce fracture risk but do not reverse established articular cartilage loss.

Intra-articular injections: Corticosteroid injection provides short-term (6–12 weeks) pain relief for knee OA and shoulder conditions. Hyaluronic acid (viscosupplementation) provides modest pain relief for knee OA with a more prolonged effect in some patients; mechanism and clinical magnitude of benefit remain debated. Platelet-rich plasma (PRP) has emerging evidence for knee OA and tendinopathy but is not yet recommended by NICE or AAOS as standard of care. All injections are contraindicated within 3 months of planned joint replacement due to increased infection risk.

Orthotic devices and assistive equipment: Valgus knee unloader brace for medial compartment OA; patellofemoral bracing for patellofemoral syndrome; custom foot orthoses for flatfoot, plantar fasciitis, and Achilles tendinopathy; wrist splints for carpal tunnel syndrome (first-line before surgical decompression); walking aids (cane, crutch) to offload arthritic joints and improve safety and confidence.

Watchful waiting: Many orthopedic conditions have favourable natural histories without intervention — lumbar disc herniation (70–80% resolve within 12 weeks), adhesive capsulitis (most resolve within 12–18 months), minor meniscal tears (degenerative horizontal tears often respond to physiotherapy alone), and mild ACL sprains without complete rupture. Serial clinical review while conservative measures are implemented is appropriate before committing to surgical intervention.